The skin absorption of hypericin was evaluated in hairless mice to develop
an optimised hypericin topical formulation that could be used in the clinic
al study of psoriasis.
Hypericin (0.01-1.0%) in Beeler basis, polyethylene glycol ointment, carbop
ol gel, cetomacrogol cream, petrolatum or emulsifying ointment, with and wi
thout skin-absorption enhancers (isopropylidene glycerol and diethylene gly
col monoethyl ether), was tested in-vivo on hairless mice skin. Using a ski
n-stripping technique and the intrinsic fluorescence of hypericin under sta
ndardised UV365 irradiation, it was demonstrated that the absorption of hyp
ericin very much depended on the vehicle used. The concentrations of hyperi
cin in the skin were then estimated by HPLC analysis. For this purpose, two
vehicles were employed, with which hypericin penetrated the skin of hairle
ss mice well (emulsifying ointment with isopropylidene glycerol) or very po
orly (polyethylene glycol ointment). In the case of emulsifying ointment wi
th isopropylidene glycerol (0.05% hypericin), a substantial concentration o
f hypericin (8.6 +/- 32 mu g g(-1)) (mean +/- s.d., n = 5) was found in the
skin. With polyethylene glycol ointment, however, only a limited hypericin
skin concentration (0.38 +/- 0.34 mu g g(-1), n = 5) was achieved.
These results show that emulsifying ointment with polyethylene glycol holds
promise as an effective topical vehicle for the treatment of skin diseases
, such as psoriasis, with hypericin.